Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Barker, J.
Right arrow Articles by Brown, M. R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barker, J.
Right arrow Articles by Brown, M. R. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1995) 36, 7-21
© 1995 The British Society for Antimicrobial Chemotherapy

review-article

Speculations on the influence of infecting phenotype on virulence and antibiotic susceptibility of Legionella pneumophila

J. Barkera,* and M. R. W. Brownb

aHealth Research Institute, Department of Biomedical Sciences, Sheffield Hallam University Pond Street, Sheffield SI IWB bDepartment of Pharmaceutical and Biological Sciences, Aston University Birmingham B4 7ET, UK

Received 19 December 1994; returned 1 March 1995; accepted 12 April 1995

*Phone: +44-(l 14)-2533OO4; Fax: + 44-(l 14)-2532020.

It is not clear how Legionella pneumophila, which is a ubiquitous aquatic organism not possessing a mammalian reservoir, evolved the ability to cause human disease. The unusual ecology of the organism may play an important role in the transmission and virulence of legionella infections. L. pneumophila can infect and kill specific species of free-living amoebae as well as multiplying as an intracellular parasite in human phagocytic cells. In nature L. pneumophilacan survive and possibly replicate in free suspension, and grow in biofilms and in protozoa thus leading to diverse phenotypes, potentially with diverse virulence and susceptibility properties. Indeed, recent evidence shows that intra-amoeba growth induces a phenotype that is dramatically different physiologically to that obtained in vitro, with altered virulence and susceptibility properties. Growth in macrophages also has profound effect on the physiological properties of L. pneumophila. Many different stress proteins are expressed by the organism as a result of intra-macrophage growth. A heat shock protein is abundantly synthesised and may be presented onthe surface of infected macrophages, which allows them to be targeted by T-lymphocytes for destruction. The difficulties in successfully treating Legionnaires' disease are probably influenced by the intracellular location of L. pneumophila. Retrospective clinical studies show that it is only drugs such as erythromycin, ciprofloxacin and rifampicin, which are capable of accumulating in phagocytic cells, that are efficacious in the treatment of legionnaires' disease. Despite the use of such drugs treatment failures occur, but these do not appear to be associated with the emergence of resistant strains. Studies have shown that although erythromycin and rifampicin can inhibit the multiplication of L. pneumophila in macrophages the organism is not killed and can resume multiplying when the drugs are removed. Thus a competent cell mediated immune response is important in recovery from legionella infections. There is an urgent need forgreater understanding of how the changes induced by intracellular growth affect sensitivity to antibiotics and host defences. Immunocompromised patients, who have the highest mortality rates, are likely to gain the most from progress in the treatment of L. pneumophila infections.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
P. Bandyopadhyay, H. Xiao, H. A. Coleman, A. Price-Whelan, and H. M. Steinman
Icm/Dot-Independent Entry of Legionella pneumophila into Amoeba and Macrophage Hosts
Infect. Immun., August 1, 2004; 72(8): 4541 - 4551.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. A. Garduno, E. Garduno, M. Hiltz, and P. S. Hoffman
Intracellular Growth of Legionella pneumophila Gives Rise to a Differentiated Form Dissimilar to Stationary-Phase Forms
Infect. Immun., November 1, 2002; 70(11): 6273 - 6283.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
B. W. James, W. S. Mauchline, P. J. Dennis, C. W. Keevil, and R. Wait
Poly-3-Hydroxybutyrate in Legionella pneumophila, an Energy Source for Survival in Low-Nutrient Environments
Appl. Envir. Microbiol., February 1, 1999; 65(2): 822 - 827.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
A. L. Baltch, R. P. Smith, M. A. Franke, and P. B. Michelsen
Antibacterial Effects of Levofloxacin, Erythromycin, and Rifampin in a Human Monocyte System against Legionella pneumophila
Antimicrob. Agents Chemother., December 1, 1998; 42(12): 3153 - 3156.
[Abstract] [Full Text]

Home page
 NEJMHome page
J. E. Stout and V. L. Yu
Legionellosis
N. Engl. J. Med., September 4, 1997; 337(10): 682 - 687.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.